Complete Relief of Painful Tonic Seizures in Neuromyelitis Optica Spectrum Disorder by Satralizumab Treatment

Satralizumab, a monoclonal antibody against interleukin-6 receptors, has been approved for the treatment of neuromyelitis optica spectrum disorder (NMOSD). Several reports have described the effectiveness of satralizumab against neuropathic pain in patients with NMOSD, but its effects on painful ton...

Descripción completa

Detalles Bibliográficos
Autores principales: Uzawa, Akiyuki, Mori, Masahiro, Iwai, Yuta, Masuda, Hiroki, Kuwabara, Satoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556229/
https://www.ncbi.nlm.nih.gov/pubmed/35135926
http://dx.doi.org/10.2169/internalmedicine.9036-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556229/
https://www.ncbi.nlm.nih.gov/pubmed/35135926
http://dx.doi.org/10.2169/internalmedicine.9036-21

Ejemplares similares